rs121918148
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000312.4(PROC):c.185A>C(p.Glu62Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E62E) has been classified as Likely benign.
Frequency
Consequence
NM_000312.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
PP1_moderate, PP3, PM1, PM2_moderate, PS3_moderate, PS4_moderate -
Thrombophilia due to protein C deficiency, autosomal recessive Pathogenic:1
- -
PROC-related disorder Pathogenic:1
The PROC c.185A>C variant is predicted to result in the amino acid substitution p.Glu62Ala. This variant, also referred to a p.Glu20Ala using legacy nomenclature, was shown to segregate in multigeneration family with protein C deficiency who also carried another missense change p.Val76Met (referred to as p.Val34Met in the paper). These two variants together were referred to as Protein C Vermont (Bovill EG et al 1992. PubMed ID: 1347706). Another missense change at the same amino acid postion, c.184G>A (p.Glu62Lys) has previously been reported to be causative for protein C deficiency (Alhenc-Gelas et al 2020. PubMed ID: 32717757). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at